Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...
Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a patent dispute related to Pfizer (PFE) ...
Warminster-based Arbutus Biopharma has cranked up its legal war over COVID‑19 vaccine delivery technology, rolling out a new ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid ...
The State of Oregon and the nonprofit healthcare system PeaceHealth both issued mandates in 2021 requiring healthcare workers ...
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...
None of us will ever forget the Covid-19 pandemic. A virus we had never seen before sparked a pandemic, and we had no ...
The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their ...
The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.
Check out the latest Biontech Se (BNTX) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
A longevity gene therapy targeting the molecular mechanism behind why some people live to 100 has maintained its early benefits three months after dosing aged beagles — and the Vancouver firm whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results